Although it is not BRCA-deficient, Ewing sarcoma is also characterized by defective HR (96), further supporting the idea that cancers with defective DNA repair mechanisms may have increased susceptibility to NAMPT inhibition. The gene discussed is NAMPT; the disease is Ewing sarcoma.